Efficacy and safety of inhaled zanamivir for the treatment of influenza in patients with asthma or chronic obstructive pulmonary disease: A double-blind, randomised, placebo-controlled, multicentre study

Clinical Drug Investigation

Volumn 20, Issue 5, 2000, Pages 337-349

  Murphy, Kevin R ^a   Eivindson, Arne ^b   Pauksens, Karlis ^c   Stein, William J ^d   Tellier, Guy ^e   Watts, Richard ^f   Léophonte, Paul ^g   Sharp, Stephen J ^h   Loeschel, Elke ^h  

^a Midwest Allergy and Asthma Clinic   (United States)

^b Havblik Medical Center   (Norway)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^d Twelve Corners Middle School   (United States)

^e Hosp Hotel Dieu de St Jerome   (Canada)

^f Investigator Clinic   (Australia)

^g CHU RANGUEIL   (France)

^h GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PLACEBO; ZANAMIVIR;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; CHILD; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; INFLUENZA; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SLEEP DISORDER; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 0033678542     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-200020050-00005     Document Type: Article

References (43)

1. Surveillance of influenza
2. Human influenza
3. Clinical manifestations and consequences of influenza
4. Survey of underlying con, ditions of persons hospitalized with acute respiratory disease during influenza epidemics in Houston, 1978-1981
5. Pneumonia and influenza deaths during epidemics: Implications for prevention
6. Impact of influenza epidemics on mortality in the United States from October 1972 to May 1985
7. Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
8. Prevention and control of influenza recommendations of the Advisory Committee on Immunization Practices
9. Improving influenza vaccination rates in children with asthma: A test of a computerized reminder system and an analysis of factors predicting vaccination compliance
10. Influenza and asthma
11. Emergence and apparent transmission of rimantadine-resistant influenza A VirUS in families
12. Amantadine and rimantadine resistance in influenza A viruses
13. Resistance of influenza A virus to amantadine and rimantadine: Results of one decade of surveillance
14. Comparative toxicity of amamadine hydrochloride and rimantadine hydrochloride in healthy adults
15. Differences in side effects of amantadine hydrochloride and rimantadine hydrochloride relate to differences in pharmacokinetics
16. Amantadine and rimantadine
17. 4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro
18. Zanamivir susceptibility monitoring and characterization of influenza virus clinical isolates obtained during phase II clinical efficacy studies
19. A double-blind, randomised trial of zanamivir in the treatment of acute influenza: Clinical and virological efficacy results
20. Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections
21. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza virus infections. GG167 Influenza Study Group
22. Clinical efficacy and safety of the orally inhaled neuraminidase inhibitor zanamivir in the treatment of influenza: A randomised, double-blind, placebo-controlled European study
23. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza A and B virus infections
24. Zanamivir for the treatment of influenza A and B infection in high-risk patients: A pooled analysis of randomized controlled trials
25. The incidence of respiratory tract infection in adults requiring hospitalization for asthma
26. The effects of influenza virus infection on FEVI in asthmatic children. The time-course study
27. Viral respiratory infections in asthmatic children staying in a mountain resort
28. Descriptive epidemiology of asthma
29. Respiratory distress associated with zanamivir
30. Pulmonary function and airway responsiveness in mild to moderate asthmatics given repeated inhaled doses of zanamivir
31. Sample size determination for some common nonparametric tests
32. Respiratory viruses and exacerbations of asthma in adults
33. Severe exacerbations of COPD patients: The role of pulmonary infections
34. Obstructive lung disease and sleep
35. Sleep in patients with respiratory disease
36. Sleep in asthma
37. Does influenza vaccination exacerbate asthma?
38. Randomised placebo-controlled crossover trial on effect of inactivated influenza vaccine on pulmonary function in asthma